Literature DB >> 29401359

Anti-phospholipase A2 receptor antibodies in primary membranous nephropathy-10 key points.

Emily P McQuarrie1.   

Abstract

Entities:  

Year:  2018        PMID： 29401359     DOI： 10.1093/ndt/gfx366

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  3 in total

1.  Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.

Authors:  Yaling Guo; Xueping Wu; Lei Liu; Haifeng Zhang; Lijuan Yang; Weidong Chen
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

2.  Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer.

Authors:  Le Deng; Qipeng Huang; Jiang Wang; Kaiping Luo; Jiarong Liu; Wenjun Yan; Fang Jiang; Gaosi Xu
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

3.  Clinical value of a serum anti-PLA2R antibody in the diagnosis and monitoring of primary membranous nephropathy in adults.

Authors:  Xueping Wu; Lei Liu; Yaling Guo; Lijuan Yang
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-09-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.